Neurizon Therapeutics Limited (ASX:NUZ)
Australia · Delayed Price · Currency is AUD 0.0620
+0.0025 (4.20%)
Jul 31, 2026, 4:10 PM AEST
Neurizon Therapeutics Market Cap
Neurizon Therapeutics has a market cap or net worth of 46.27 million as of July 31, 2026. Its market cap has decreased by -41.26% in one year.
Market Cap
46.27M
Enterprise Value
39.94M
Revenue
5.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
ChartMarket Cap Chart
Since September 12, 2002, Neurizon Therapeutics's market cap has increased from 4.18M to 46.27M, an increase of 1,006.07%. That is a compound annual growth rate of 10.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 46.27M | 1.60% |
| Dec 31, 2025 | 45.54M | -45.58% |
| Dec 31, 2024 | 83.69M | 94.55% |
| Dec 29, 2023 | 43.02M | 112.09% |
| Dec 30, 2022 | 20.28M | -36.00% |
| Dec 31, 2021 | 31.69M | -4.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avecho Biotechnology | 76.61M |
| Arovella Therapeutics | 76.15M |
| Immutep | 69.26M |
| Amplia Therapeutics | 66.73M |
| Entropy Neurodynamics | 57.11M |
| Radiopharm Theranostics | 55.00M |
| Botanix Pharmaceuticals | 51.95M |
| Nexsen | 48.05M |